A Randomized, Open-label, Phase I, Crossover Study to Assess the Effect of Food on the Bioavailability of AXL1717, in Patients With Advanced Malignant Tumors
Latest Information Update: 07 Nov 2021
At a glance
- Drugs Picropodophyllin (Primary)
- Indications Haematological malignancies; Solid tumours
- Focus Pharmacokinetics
- Sponsors Axelar
- 04 Apr 2014 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 14 Dec 2012 New trial record